Hepatitis B DNA vaccine - ChronTech PharmaAlternative Names: ChronVac-B
Latest Information Update: 15 Nov 2014
At a glance
- Originator Inovio Biomedical Corporation; Tripep
- Developer ChronTech Pharma; Inovio Pharmaceuticals
- Class DNA vaccines; Hepatitis B vaccines
- Mechanism of Action Gene transference; Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Hepatitis B